13F filer · CIK 1103804 ↗
Viking Global
You are looking at Q1 2023. See the latest, Q2 2026 →
Reported value
$21.31B
+6.7% on the quarter before
Positions
81
20 new · 15 sold out
Top 10
42.9%
of the value
Est. gain
+$776.2M
on stocks held all quarter
Est. return
+5.1%
on those stocks since Q4 2022
Positions as of Mar 31, 2023, from Viking Global's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2022. Striped tiles are options.
Largest buys
Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Lululemon Athletica Inc~$689.7MNew · 0.0% → 3.2%+1,893,883 shares
- Sherwin Williams Co~$506.2MNew · 0.0% → 2.4%+2,252,060 shares
- Unitedhealth Group Inc~$393.3MAdded · 3.4% → 4.7%+832,288 shares
- Mckesson Corp~$357.0MAdded · 4.1% → 5.4%+1,002,662 shares
- Fortinet~$315.6MAdded · 1.7% → 3.7%+4,748,557 shares
- Emerson Electric~$209.2MNew · 0.0% → 1.0%+2,400,879 shares
- Csx Corp~$194.9MAdded · 2.4% → 3.1%+6,508,996 shares
- Meta~$178.5MAdded · 1.4% → 3.2%+842,184 shares
- Visa Inc.~$174.8MAdded · 6.0% → 6.9%+775,098 shares
- Fortive Corp~$167.4MAdded · 1.3% → 2.0%+2,455,928 shares
Largest sells
Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Microsoft~$686.7MCut · 4.1% → 1.4%−2,381,775 shares
- Amazon~$501.3MCut · 5.2% → 3.7%−4,853,738 shares
- Boston Scientific Corp~$419.8MCut · 2.2% → 0.3%−8,391,712 shares
- Micron~$332.0MCut · 2.1% → 0.8%−5,502,109 shares
- Mastercard~$331.6MCut · 3.0% → 1.4%−912,488 shares
- Biomarin Pharmaceutical Inc~$301.9MCut · 2.7% → 1.0%−3,105,003 shares
- Brookfield Corp~$228.5MSold out · 1.1% → 0.0%−7,262,078 shares
- Ameriprise Finl Inc~$216.6MCut · 2.6% → 1.4%−706,815 shares
- Rh~$200.0MSold out · 1.0% → 0.0%−748,344 shares
- Uber~$196.4MSold out · 1.0% → 0.0%−7,939,999 shares
Holdings
As of Mar 31, 2023. Changes are in shares against Dec 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Visa Inc.COM CL A · shares +13% · price +8.5% | 6.9% | $1.48B | +$102.4M | ||||||||
| Mckesson CorpCOM · shares +45% · price −5.1% | 5.4% | $1.14B | −$42.0M | ||||||||
| Unitedhealth Group IncCOM · shares +66% · price −10.9% | 4.7% | $992.4M | −$73.0M | ||||||||
| Elevance Health IncCOM · shares +15% · price −10.4% | 4.6% | $990.7M | −$99.5M | ||||||||
| General Electric CoCOM NEW · shares +11% · price +14.1% | 3.9% | $823.3M | +$91.8M | ||||||||
| FortinetCOM · shares +67% · price +35.9% | 3.7% | $789.2M | +$125.2M | ||||||||
| AmazonCOM · shares −39% · price +23.0% | 3.7% | $787.9M | +$147.1M | ||||||||
| Api Group CorpCOM STK · shares +0.8% · price +19.5% | 3.6% | $766.3M | +$124.1M | ||||||||
| Lululemon Athletica IncCOM · shares New | 3.2% | $689.7M | — | ||||||||
| MetaCL A · shares +35% · price +76.1% | 3.2% | $684.5M | +$218.7M | ||||||||
| Chubb LimitedCOM · shares −3.2% · price −12.0% | 3.2% | $673.2M | −$91.6M | ||||||||
| Csx CorpCOM · shares +42% · price −3.4% | 3.1% | $660.4M | −$16.2M | ||||||||
| Roivant Sciences LtdSHS · shares 0% · price −7.6% | 3.1% | $651.2M | −$53.8M | ||||||||
| Hdfc Bank LtdSPONSORED ADS · shares −3.3% · price −2.5% | 2.6% | $552.4M | −$14.4M | ||||||||
| IntuitCOM · shares +3.3% · price +14.5% | 2.6% | $544.4M | +$66.9M | ||||||||
| Sherwin Williams CoCOM · shares New | 2.4% | $506.2M | — | ||||||||
| Thermo Fisher Scientific IncCOM · shares +2.1% · price +4.7% | 2.3% | $493.9M | +$21.6M | ||||||||
| Bridgebio Pharma IncCOM · shares 0% · price +117.6% | 2.1% | $441.4M | +$238.5M | ||||||||
| Fortive CorpCOM · shares +63% · price +6.1% | 2.0% | $432.6M | +$15.3M | ||||||||
| Royalty Pharma PlcSHS CLASS A · shares +12% · price −8.8% | 1.9% | $403.7M | −$34.9M | ||||||||
| Seagate Technology Hldngs PlORD SHS · shares −11% · price +25.7% | 1.7% | $364.6M | +$74.5M | ||||||||
| MicrosoftCOM · shares −69% · price +20.2% | 1.4% | $302.0M | +$50.8M | ||||||||
| MastercardCL A · shares −53% · price +4.5% | 1.4% | $289.5M | +$12.5M | ||||||||
| Ameriprise Finl IncCOM · shares −43% · price −1.6% | 1.4% | $288.4M | −$4.6M | ||||||||
| Karuna Therapeutics IncCOM · shares +27% · price −7.6% | 1.3% | $272.7M | −$17.6M | ||||||||
| Total · 81 positions | 100% | $21.31B | +$776.2M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2022 to Q1 2023: 60 stocks held throughout, up $776.2M (+5.1%).
- Bridgebio Pharma Inc+$238.5M+118%
- Meta+$218.7M+76%
- Amazon+$147.1M+23%
- Fortinet+$125.2M+36%
- Api Group Corp+$124.1M+20%
- Mckesson Corp−$42.0M−5%
- Roivant Sciences Ltd−$53.8M−8%
- Unitedhealth Group Inc−$73.0M−11%
- Chubb Limited−$91.6M−12%
- Elevance Health Inc−$99.5M−10%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $35.08B−2% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $35.75B−5% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $37.68B−2% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $38.50B+11% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $34.59B+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $31.48B+2% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $30.90B+13% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.44B+5% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $26.02B−3% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $26.86B−2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $27.30B+11% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $24.64B+1% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $24.43B+15% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $21.31B+7% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $19.98B−8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $21.66B−1% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $21.86B−12% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $24.74B−29% | SEC ↗ |
| Q4 2021 | May 16, 2022 (amended) | $34.71B−5% | SEC ↗ |
| Q3 2021 | May 16, 2022 (amended) | $36.46B+11% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $32.98B−2% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $33.58B−8% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $36.37B+31% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $27.68B+20% | SEC ↗ |
| Q2 2020 | Aug 7, 2020 | $23.14B+20% | SEC ↗ |
| Q1 2020 | May 13, 2020 | $19.21B−10% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $21.35B+11% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $19.20B−14% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $22.29B+28% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $17.44B−1% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $17.57B−3% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $18.06B+3% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $17.47B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $16.61B+2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $16.26B+5% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $15.44B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $14.85B−34% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $22.64B+3% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $22.01B−5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $23.18B−2% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $23.54B+4% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $22.72B | SEC ↗ |